Mizuho Securities USA’s SAB Biotherapeutics SABS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-29,448	Closed	-$2.93M	–	206
2021 Q3	$2.93M	Buy	29,448 +2,520	+9%	+$251K	0.3%	92
2021 Q2	$2.65M	Sell	26,928 -2,064	-7%	-$203K	0.21%	84
2021 Q1	$2.84M	Buy	+28,992	New	+$2.84M	0.27%	76